The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1H-indol-3-yl)-2-methyl-2H-benzo[d][1,2,3]triazol-4-amine ID: ALA4858642
PubChem CID: 164613638
Max Phase: Preclinical
Molecular Formula: C14H11N5
Molecular Weight: 249.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1c(-c2c[nH]c3ccccc23)ccc2[nH]nnc12
Standard InChI: InChI=1S/C14H11N5/c15-13-9(5-6-12-14(13)18-19-17-12)10-7-16-11-4-2-1-3-8(10)11/h1-7,16H,15H2,(H,17,18,19)
Standard InChI Key: XCKZNNNHJDXOHT-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
35.0016 -4.5647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0005 -5.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7085 -5.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7067 -4.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4153 -4.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4201 -5.3797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2002 -5.6281 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.6775 -4.9630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1924 -4.3036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4404 -3.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2405 -3.3551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1361 -2.1503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8917 -2.9279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9405 -1.9693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4856 -2.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2302 -2.2437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.1452 -1.4332 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.3481 -1.2637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7902 -3.9598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 0
11 15 1 0
14 12 1 0
12 13 2 0
13 10 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 1 0
11 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 249.28Molecular Weight (Monoisotopic): 249.1014AlogP: 2.69#Rotatable Bonds: 1Polar Surface Area: 83.38Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.37CX Basic pKa: 1.35CX LogP: 2.22CX LogD: 2.21Aromatic Rings: 4Heavy Atoms: 19QED Weighted: 0.45Np Likeness Score: -0.59
References 1. Kozlova A, Thabault L, Liberelle M, Klaessens S, Prévost JRC, Mathieu C, Pilotte L, Stroobant V, Van den Eynde B, Frédérick R.. (2021) Rational Design of Original Fused-Cycle Selective Inhibitors of Tryptophan 2,3-Dioxygenase., 64 (15.0): [PMID:34338527 ] [10.1021/acs.jmedchem.1c00323 ] 2. Kozlova A, Thabault L, Liberelle M, Klaessens S, Prévost JRC, Mathieu C, Pilotte L, Stroobant V, Van den Eynde B, Frédérick R.. (2021) Rational Design of Original Fused-Cycle Selective Inhibitors of Tryptophan 2,3-Dioxygenase., 64 (15.0): [PMID:34338527 ] [10.1021/acs.jmedchem.1c00323 ]